Skip Navigation
Grant Details

Grant Number: 5R01CA081200-03 Interpret this number
Primary Investigator: Toniolo, Paolo
Organization: New York University School Of Medicine
Project Title: Endogenous Steroids and Cancer of the Ovary
Fiscal Year: 2001
Back to top


Abstract

This proposal is Component 1 of a group of 3 Investigator- Initiated Research Project Grants (IRPG) that are submitted concurrently. The three projects address complementary aspects of the role of endogenous hormones in the etiology of the most common cancers specific to women-ovary, endometrium and breast. All studies are based on the same underlying population, obtained by combining three prospective cohort studies that are under way in New York, Umea (Sweden) and Milan (Italy). The present proposal addresses the potential role of a hyperandrogenic steroid profile in ovarian cancer. The second proposal focuses on hyperandrogenism and estrogens in endometrial cancer and the third (Component 3) on insulin IGF-I as the common determinant of hyperandrogenism in ovarian and endometrial cancers, and in breast cancer in young women. The study seeks to evaluate the hypothesis that the risk of epithelial ovarian cancer is increased in women who experience excessive ovarian androgen production, either as an etiologic factor per se, or as a reflection of chronic ovarian over- stimulation by gonadotropins. The primary aim is to determine whether pre-diagnostic blood levels of the major androgens of ovarian stromal origin, androstenedione and testosterone, are positively associated with the risk of epithelial ovarian cancer in both premenopausal and postmenopausal women. Secondary aim is to show that pre-diagnostic blood levels of SHBG are negatively associated with ovarian cancer in both premenopausal and postmenopausal women. A case-control study (approximately 143 cases and 286 controls) will be nested within the three joint cohort studies. Cases will be women diagnosed with epithelial ovarian cancer after entering any of the three cohort studies. Controls will be women randomly selected from among all eligible individuals from the same cohorts and matching a given case on specified criteria. The study duration will be three years.

Back to top


Publications

Circulating enterolactone and risk of endometrial cancer.
Authors: Zeleniuch-Jacquotte A, Lundin E, Micheli A, Koenig KL, Lenner P, Muti P, Shore RE, Johansson I, Krogh V, Lukanova A, Stattin P, Afanasyeva Y, Rinaldi S, Arslan AA, Kaaks R, Berrino F, Hallmans G, Toniolo P, Adlercreutz H
Source: Int J Cancer, 2006 Nov 15;119(10), p. 2376-81.
PMID: 16929490
Related Citations

Back to top


Endogenous hormones and ovarian cancer: epidemiology and current hypotheses.
Authors: Lukanova A, Kaaks R
Source: Cancer Epidemiol Biomarkers Prev, 2005 Jan;14(1), p. 98-107.
PMID: 15668482
Related Citations

Back to top


Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women.
Authors: Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P, Shore RE, Krogh V, Koenig KL, Riboli E, Berrino F, Hallmans G, Stattin P, Toniolo P, Kaaks R
Source: Eur J Endocrinol, 2004 Feb;150(2), p. 161-71.
PMID: 14763914
Related Citations

Back to top


Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.
Authors: Arslan AA, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Lukanova A, Afanasyeva Y, Lenner P, Krogh V, Muti P, Rinaldi S, Kaaks R, Berrino F, Hallmans G, Toniolo P
Source: Cancer Epidemiol Biomarkers Prev, 2003 Dec;12(12), p. 1531-5.
PMID: 14693749
Related Citations

Back to top


Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
Authors: Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, Krogh V, Lenner P, Shore RE, Biessy C, Muti P, Riboli E, Koenig KL, Levitz M, Stattin P, Berrino F, Hallmans G, Kaaks R, Toniolo P, Zeleniuch-Jacquotte A
Source: Int J Cancer, 2004 Jan 20;108(3), p. 425-32.
PMID: 14648710
Related Citations

Back to top


Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
Authors: Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, Muti P, Lenner P, Koenig KL, Biessy C, Krogh V, Riboli E, Shore RE, Stattin P, Berrino F, Hallmans G, Toniolo P, Kaaks R
Source: Int J Cancer, 2004 Jan 10;108(2), p. 262-8.
PMID: 14639613
Related Citations

Back to top


Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy).
Authors: Lukanova A, Lundin E, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, Riboli E, Hallmans G, Berrino F, Zeleniuch-Jacquotte A, Toniolo P, Kaaks R
Source: Cancer Causes Control, 2003 Apr;14(3), p. 285-92.
PMID: 12814208
Related Citations

Back to top


Circulating levels of sex steroid hormones and risk of ovarian cancer.
Authors: Lukanova A, Lundin E, Akhmedkhanov A, Micheli A, Rinaldi S, Zeleniuch-Jacquotte A, Lenner P, Muti P, Biessy C, Krogh V, Berrino F, Hallmans G, Riboli E, Kaaks R, Toniolo P
Source: Int J Cancer, 2003 May 1;104(5), p. 636-42.
PMID: 12594820
Related Citations

Back to top


Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
Authors: Kaaks R, Lukanova A, Kurzer MS
Source: Cancer Epidemiol Biomarkers Prev, 2002 Dec;11(12), p. 1531-43.
PMID: 12496040
Related Citations

Back to top


Circulating levels of insulin-like growth factor-I and risk of ovarian cancer.
Authors: Lukanova A, Lundin E, Toniolo P, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, Zeleniuch-Jacquotte A, Berrino F, Hallmans G, Riboli E, Kaaks R
Source: Int J Cancer, 2002 Oct 20;101(6), p. 549-54.
PMID: 12237896
Related Citations

Back to top